Skip to main content
. Author manuscript; available in PMC: 2014 Jun 28.
Published in final edited form as: Neurosci Lett. 2013 May 10;547:16–20. doi: 10.1016/j.neulet.2013.04.056

Fig 1. RNF11 expression is reduced in PD.

Fig 1

A - Sections through the cingulate cortex from control (A, left panel) and PD (A, right panel) brains were immunostained for RNF11 using diaminobenzadine (DAB) as the chromophore. Representative images are shown in (A). B - The sections were blind scored by four independent individuals on a rating scale of 1 (low RNF11 immunoreactivity as in PD sections) to 4 (high RNF11 immunoreactivity as in control sections). Average score for each case was plotted with the mean for each group demonstrated by the bar in (B). * P < 0.05. Note the reduced RNF11-immunoreactivity in PD confirmed by semi-quantitative analysis. Scale bar − 100µm.